AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Buprenorphine Hydrochloride Equivalent To Buprenorphine

9 registrations across 1 African market— 6 active

Markets with Buprenorphine Hydrochloride Equivalent To Buprenorphine

🇿🇦South Africa
9 registrations
6 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
SOBRIXA 8,0 mg🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveFeb 2030
SOBRIXA 2,0 mg🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveFeb 2030
SOBRIXA 0,4 mg🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveFeb 2030
SUBUTEX SUBLINGUAL 0,4 mg🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdsuspendedMar 2026
SUBUTEX SUBLINGUAL 2,0 mg🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdsuspendedMar 2026
SUBUTEX SUBLINGUAL 8,0 mg🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdsuspendedMar 2026
TEmgESIC 1 ml🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveJan 1900
TEmgESIC SUBLINGUAL TABLETS🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveJan 1900
TEmgESIC 2 ml🇿🇦South AfricaReckitt Benckinser Pharmaceuticals (Pty) LtdactiveJan 1900

Buprenorphine Hydrochloride Equivalent To Buprenorphine in Africa — Regulatory Overview

Buprenorphine Hydrochloride Equivalent To Buprenorphine is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.